Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • sophix
    Junior Member
    • Oct 2013
    • 3

    vcf-consensus for individuals from 1000G

    Hi,

    I would like to create consensus sequence for an individual from 1000G where the sequence incorporates variants typed for this individual.

    Using tabix and vcf-tools (vcf-subset), I extracted the relevant variant information from 1000G SNP call files.

    At this point, I have variants per chromosome for individual HG000096.

    I would like to incorporate these variants into reference coding sequence.

    I downloaded all protein-coding sequences for the GRCh37 version from Ensembl Biomart.

    An example with trimmed sequence looks like this:

    Code:
    >ENSG00000003137|ENST00000001146|ENSP00000001146|2|72356367|72375167
    ATGCTCTTTGAGGGCTTGGATCTGGTGTCGGCGCTGGCCACCCTCGCCGCGTGCCTGGTG
    TCCGTGACGCTGCTGCTGGCCGTGTCGCAGCAGCTGTGGCAGCTGCGCTGGGCCGCCACT
    CGCGACAAGAGCTGCAAGCTGCCCATCCCCAAGGGATCCATGGGCTTCCCGCTCATCGGA
    Note: typical fasta sequence file with the header including gene|transcript|protein|chr|chr_start|chr_end

    My understanding is that there are a few alternatives out there to produce consensus sequences given a reference fasta sequence and variant call file: (1) AlternativeReferenceMaker, (2) vcf-consensus, (3) mpileup.

    I would like to use vcf-consensus for my task.

    vcftools describes the use of vcf-consensus as follows:

    Code:
    cat ref.fa | vcf-consensus file.vcf.gz > out.fa
    I presume that the reference file here refers to the reference DNA sequence including coding and non-coding parts of the genome. In that case, my protein-coding sequence above would not work as an acceptable reference sequence. Nevertheless, I am only interested in the protein-coding part.

    How can I modify vcf-consensus or my input sequences to create consensus coding sequence for HG00096 given the reference coding sequence and his variants?

    Thank you very much.

    As soon as I figure out a way to get this done, I will have a follow-up question concerning the diploidy, that is, how can I tell whether a variant is called at a heterozygous site or not.
  • lindenb
    Senior Member
    • Apr 2010
    • 143

    #2
    cross posted on biostars: http://www.biostars.org/p/85681/

    Comment

    • sophix
      Junior Member
      • Oct 2013
      • 3

      #3
      cross posted on biostars: http://www.biostars.org/p/85681/
      Yes! Thank you for the link.

      Comment

      • rajeshkmaurya08
        Member
        • Feb 2017
        • 14

        #4
        Can anybody help to figure out this problem?

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        30 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        212 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        78 views
        0 reactions
        Last Post SEQadmin2  
        Working...